› $150,000,000 verdict in personal injury case
After four weeks of testimony and a full day of closing arguments, jurors will begin deliberating this morning to decide whether pharmaceutical giant Wyeth is responsible for the breast cancer suffered by three Northern Nevada women who took the company’s hormone replacement drugs.
The Reno trial involving three breast cancer survivors who are suing Wyeth is now nearing the end of its fourth week. The Nevada plaintiffs are suing Wyeth, the manufacturer of Prempro and Premarin, after they each developed breast cancer attributed to their long-term use of combination hormone replacement drugs.
